Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide for Anemia in CKD with PRCA
NCT00314795Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2006
- Primary completion
- Oct 2016
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 3
01
Overview
A Phase 2 trial of peginesatide in anemia, sponsored by Takeda. Started Apr 2006; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00314795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314795.